Cargando…
The occurrence of interval cancers in the Nijmegen screening programme.
Since January 1975 a population-based screening programme for the early detection of breast cancer has been carried out in the city of Nijmegen. During five interscreening periods of 2 years each a total of 158 so-called interval cancers were diagnosed. Careful revision of all screening and diagnost...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246722/ https://www.ncbi.nlm.nih.gov/pubmed/2736229 |
_version_ | 1782150828062146560 |
---|---|
author | Peeters, P. H. Verbeek, A. L. Hendriks, J. H. Holland, R. Mravunac, M. Vooijs, G. P. |
author_facet | Peeters, P. H. Verbeek, A. L. Hendriks, J. H. Holland, R. Mravunac, M. Vooijs, G. P. |
author_sort | Peeters, P. H. |
collection | PubMed |
description | Since January 1975 a population-based screening programme for the early detection of breast cancer has been carried out in the city of Nijmegen. During five interscreening periods of 2 years each a total of 158 so-called interval cancers were diagnosed. Careful revision of all screening and diagnostic mammograms was executed. Of all interval cancers 26% were 'missed' at the previous screening examination (due to technical or observer error), 16% were radiographically occult at the time of diagnosis and 58% were 'true' interval cancers. Interval cancers were regarded as 'true' when an obvious lesion was observed on the diagnostic mammogram while no suspect signs were seen on the previous screening mammogram. The prevalence of 'missed' cancers did not decline in the course of the screening programme. Radiographically occult tumours were localised, mostly in Wolfe's P2/DY breast parenchyma (83%), 33% were lobular invasive and 25% ductal non-invasive. 'True' interval cancer cases (58%) showed the same overall survival as control breast cancer patients, diagnosed in a non-screening situation. Shortening the screening interval would reduce interval cancer rates and probably further decrease breast cancer mortality in a screened population. However, from the present series of interval cancers 63% would not have been prevented by an annual screening examination. As regards women under age 50 annual screening would still leave 66% of all interval cancers in this age group undetected. Probably more benefit will be gained by searching for new imaging techniques to reduce numbers of 'missed' cancers and to detect lobular invasive and ductal non-invasive cancers in dense breast parenchyma. |
format | Text |
id | pubmed-2246722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22467222009-09-10 The occurrence of interval cancers in the Nijmegen screening programme. Peeters, P. H. Verbeek, A. L. Hendriks, J. H. Holland, R. Mravunac, M. Vooijs, G. P. Br J Cancer Research Article Since January 1975 a population-based screening programme for the early detection of breast cancer has been carried out in the city of Nijmegen. During five interscreening periods of 2 years each a total of 158 so-called interval cancers were diagnosed. Careful revision of all screening and diagnostic mammograms was executed. Of all interval cancers 26% were 'missed' at the previous screening examination (due to technical or observer error), 16% were radiographically occult at the time of diagnosis and 58% were 'true' interval cancers. Interval cancers were regarded as 'true' when an obvious lesion was observed on the diagnostic mammogram while no suspect signs were seen on the previous screening mammogram. The prevalence of 'missed' cancers did not decline in the course of the screening programme. Radiographically occult tumours were localised, mostly in Wolfe's P2/DY breast parenchyma (83%), 33% were lobular invasive and 25% ductal non-invasive. 'True' interval cancer cases (58%) showed the same overall survival as control breast cancer patients, diagnosed in a non-screening situation. Shortening the screening interval would reduce interval cancer rates and probably further decrease breast cancer mortality in a screened population. However, from the present series of interval cancers 63% would not have been prevented by an annual screening examination. As regards women under age 50 annual screening would still leave 66% of all interval cancers in this age group undetected. Probably more benefit will be gained by searching for new imaging techniques to reduce numbers of 'missed' cancers and to detect lobular invasive and ductal non-invasive cancers in dense breast parenchyma. Nature Publishing Group 1989-06 /pmc/articles/PMC2246722/ /pubmed/2736229 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Peeters, P. H. Verbeek, A. L. Hendriks, J. H. Holland, R. Mravunac, M. Vooijs, G. P. The occurrence of interval cancers in the Nijmegen screening programme. |
title | The occurrence of interval cancers in the Nijmegen screening programme. |
title_full | The occurrence of interval cancers in the Nijmegen screening programme. |
title_fullStr | The occurrence of interval cancers in the Nijmegen screening programme. |
title_full_unstemmed | The occurrence of interval cancers in the Nijmegen screening programme. |
title_short | The occurrence of interval cancers in the Nijmegen screening programme. |
title_sort | occurrence of interval cancers in the nijmegen screening programme. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246722/ https://www.ncbi.nlm.nih.gov/pubmed/2736229 |
work_keys_str_mv | AT peetersph theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT verbeekal theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT hendriksjh theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT hollandr theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT mravunacm theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT vooijsgp theoccurrenceofintervalcancersinthenijmegenscreeningprogramme AT peetersph occurrenceofintervalcancersinthenijmegenscreeningprogramme AT verbeekal occurrenceofintervalcancersinthenijmegenscreeningprogramme AT hendriksjh occurrenceofintervalcancersinthenijmegenscreeningprogramme AT hollandr occurrenceofintervalcancersinthenijmegenscreeningprogramme AT mravunacm occurrenceofintervalcancersinthenijmegenscreeningprogramme AT vooijsgp occurrenceofintervalcancersinthenijmegenscreeningprogramme |